BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21697610)

  • 1. Relationship between biological variation in B-type natriuretic peptide and plasma renin concentration in stable outpatients with dilated cardiomyopathy.
    Nishiyama K; Tsutamoto T; Kawahara C; Yamaji M; Sakai H; Yamamoto T; Fujii M; Horie M
    Circ J; 2011; 75(8):1897-904. PubMed ID: 21697610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological variation of brain natriuretic peptide and cardiac events in stable outpatients with nonischemic chronic heart failure.
    Nishiyama K; Tsutamoto T; Yamaji M; Kawahara C; Fujii M; Yamamoto T; Horie M
    Circ J; 2011; 75(2):341-7. PubMed ID: 21178290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure.
    Yoshimura M; Yasue H; Okumura K; Ogawa H; Jougasaki M; Mukoyama M; Nakao K; Imura H
    Circulation; 1993 Feb; 87(2):464-9. PubMed ID: 8425293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure.
    Nishii M; Inomata T; Takehana H; Naruke T; Yanagisawa T; Moriguchi M; Takeda S; Izumi T
    J Am Coll Cardiol; 2008 Jun; 51(24):2329-35. PubMed ID: 18549918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Variation in the plasma concentration of B-type natriuretic peptide in emergent paroxysmal atrial fibrillation, in acute pulmonary embolism, in acute coronary syndrome and in dilated cardiomyopathy].
    Coppola A; De Paola G; Suppa M; Maggi B; Giancaspro G; Colzi M; Arcieri A; Scarpellini G; Manetti E; Lacenere L; Gerratana G; Santulli M; Aguglia F
    Ann Ital Med Int; 2005; 20(3):167-86. PubMed ID: 16250184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of immunoadsorption on the nt-BNP and nt-ANP plasma levels of patients suffering from dilated cardiomyopathy.
    Staudt A; Staudt Y; Hummel A; Empen K; Dörr M; Trimpert C; Birkenmeier K; Kühl U; Noutsias M; Russ D; Felix SB
    Ther Apher Dial; 2006 Feb; 10(1):42-8. PubMed ID: 16556135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical correlates of elevated plasma natriuretic peptides and Big endothelin-1 in a population of ambulatory patients with heart failure. A substudy of the Italian Network on Congestive Heart Failure (IN-CHF) registry. IN-CHF Investigators.
    Masson S; Gorini M; Salio M; Lucci D; Latini R; Maggioni AP
    Ital Heart J; 2000 Apr; 1(4):282-8. PubMed ID: 10824729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The predictability of renin-angiotensin-aldosterone system factors for clinical outcome in patients with acute decompensated heart failure.
    Nakada Y; Takahama H; Kanzaki H; Sugano Y; Hasegawa T; Ohara T; Amaki M; Funada A; Yoshida A; Yasuda S; Ogawa H; Anzai T
    Heart Vessels; 2016 Jun; 31(6):925-31. PubMed ID: 25964073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of mortality by high-sensitivity C-reactive protein and brain natriuretic peptide in patients with dilated cardiomyopathy.
    Ishikawa C; Tsutamoto T; Fujii M; Sakai H; Tanaka T; Horie M
    Circ J; 2006 Jul; 70(7):857-63. PubMed ID: 16799238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in content of plasma brain natriuretic peptide in dilated cardiomyopathy in rabbits].
    Li WQ; Li Y; Wei J; Li GC; Li GS
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Mar; 17(3):161-4. PubMed ID: 15760528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain natriuretic peptide as a potential novel marker of salt-sensitivity in chronic kidney disease patients without cardiac dysfunction.
    Hayashi M; Yasuda Y; Suzuki S; Tagaya M; Ito T; Kamada T; Yoshinaga M; Sugishita Y; Fujiwara W; Yokoi H; Ozaki Y; Izawa H
    Heart Vessels; 2017 Mar; 32(3):279-286. PubMed ID: 27385024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Within-person variation of the plasma concentration of B-type natriuretic peptide: safety range in stable patients with heart failure.
    Takeda Y; Takeda Y; Suzuki S; Kimura G
    Am Heart J; 2009 Jan; 157(1):97-101. PubMed ID: 19081403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal dysfunction is a confounder for plasma natriuretic peptides in detecting heart dysfunction in uremic and idiopathic dilated cardiomyopathies.
    Codognotto M; Piccoli A; Zaninotto M; Mion M; Plebani M; Vertolli U; Tona F; Ruzza L; Barchita A; Boffa GM
    Clin Chem; 2007 Dec; 53(12):2097-104. PubMed ID: 17934072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natriuretic peptides buffer renin-dependent hypertension.
    Demerath T; Staffel J; Schreiber A; Valletta D; Schweda F
    Am J Physiol Renal Physiol; 2014 Jun; 306(12):F1489-98. PubMed ID: 24717731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between plasma BNP level and the myocardial phosphocreatine/adenosine triphosphate ratio determined by phosphorus-31 magnetic resonance spectroscopy in patients with dilated cardiomyopathy.
    Chida K; Otani H; Kohzuki M; Saito H; Kagaya Y; Takai Y; Takahashi S; Yamada S; Zuguchi M
    Cardiology; 2006; 106(3):132-6. PubMed ID: 16636542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BNP and ANP as diagnostic and predictive markers in heart failure with left ventricular systolic dysfunction.
    Falcão LM; Pinto F; Ravara L; van Zwieten PA
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):121-9. PubMed ID: 15526247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy.
    Murdoch DR; McDonagh TA; Byrne J; Blue L; Farmer R; Morton JJ; Dargie HJ
    Am Heart J; 1999 Dec; 138(6 Pt 1):1126-32. PubMed ID: 10577444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of exercise on plasma level of brain natriuretic peptide in congestive heart failure with and without left ventricular dysfunction.
    Matsumoto A; Hirata Y; Momomura S; Suzuki E; Yokoyama I; Sata M; Ohtani Y; Serizawa T
    Am Heart J; 1995 Jan; 129(1):139-45. PubMed ID: 7817907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of dilated cardiomyopathy on the renin-angiotensin-aldosterone system, atrial natriuretic peptide activity, and thyroid hormone concentrations in dogs.
    Tidholm A; Häggström J; Hansson K
    Am J Vet Res; 2001 Jun; 62(6):961-7. PubMed ID: 11400857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure].
    Kobusiak-Prokopowicz M; Swidnicka-Szuszkowska B; Mysiak A
    Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.